The DOI matches its Crossref record.
Photodynamic therapy: novel third‐generation photosensitizers one step closer?
Open accessAbstract
Photodynamic sensitizers are drugs activated by light of a specific wavelength and are used in the photodynamic therapy (PDT) of certain diseases. Second‐ and third‐generation photosensitizers with improved PDT properties are now under investigation. In this issue of the British Journal of Pharmacology, Leung et al. have described the synthesis and investigation of a second‐generation photosensitizer (BAM‐SiPc) targeted towards the cells of HepG2 and HT29 tumours. BAM‐SiPc is selectively functionalized with bis‐amino groups and has demonstrated potent PDT activity in a small animal model. However, it also exhibited non‐selective distribution and accumulation in multiple animal (small mouse) organs and tissue. These issues highlight the importance and need for good biodistribution and localization properties for an efficacious photosensitizer. The lack of tumour specificity may have a significant impact on the potential BAM‐SiPc has in clinical PDT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Photodynamic therapy – mechanisms, photosensitizers and combinations
Kwiatkowski, S., Knap, B., Przystupski, D., Saczko, J., Kędzierska, E., Knap-Czop, K., Kotlińska, J., Michel, O., Kotowski, K., & Kulbacka, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.049 · Cited by 2,173
Oncologic photodynamic therapy photosensitizers: A clinical review
Allison, R. R., & Sibata, C. H. (2010) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2010.02.001 · Cited by 836
Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy
Awuah, S. G., & You, Y. (2012) · RSC Advances · doi:10.1039/c2ra21404k · Cited by 632
Porphyrin photosensitizers in photodynamic therapy and its applications
Kou, J., Dou, D., & Yang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.20189 · Cited by 590
An updated overview on the development of new photosensitizers for anticancer photodynamic therapy
Zhang, J., Jiang, C., Figueiró Longo, J. P., Azevedo, R. B., Zhang, H., & Muehlmann, L. A. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.09.003 · Cited by 574
Vankayala, R., & Hwang, K. C. (2018) · Advanced Materials · doi:10.1002/adma.201706320 · Cited by 557
Activatable Photosensitizers: Agents for Selective Photodynamic Therapy
Li, X., Kolemen, S., Yoon, J., & Akkaya, E. U. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201604053 · Cited by 544
Current states and future views in photodynamic therapy
Yano, S., Hirohara, S., Obata, M., Hagiya, Y., Ogura, S.-I., Ikeda, A., Kataoka, H., Tanaka, M., & Joh, T. (2011) · Journal of Photochemistry and Photobiology C: Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2011.06.001 · Cited by 540
Phthalocyanines as medicinal photosensitizers: Developments in the last five years
Li, X., Zheng, B.-D., Peng, X.-H., Li, S.-Z., Ying, J.-W., Zhao, Y., Huang, J.-D., & Yoon, J. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.08.003 · Cited by 523
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402
Nanodrug applications in photodynamic therapy
Paszko, E., Ehrhardt, C., Senge, M. O., Kelleher, D. P., & Reynolds, J. V. (2011) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2010.12.001 · Cited by 356
Orexin A/Hypocretin-1 Selectively Promotes Motivation for Positive Reinforcers
Borgland, S. L., Chang, S.-J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., & Bonci, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6096-08.2009 · Cited by 341
Upconversion-based photodynamic cancer therapy
Liu, Y., Meng, X., & Bu, W. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.09.006 · Cited by 319
Senge, M. O., & Brandt, J. C. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00986.x · Cited by 313
Xiao, L., Gu, L., Howell, S. B., & Sailor, M. J. (2011) · ACS Nano · doi:10.1021/nn1035262 · Cited by 305
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
Mahmoudi, K., Garvey, K. L., Bouras, A., Cramer, G., Stepp, H., Jesu Raj, J. G., Bozec, D., Busch, T. M., & Hadjipanayis, C. G. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03103-4 · Cited by 292
Application of Porphyrins in Antibacterial Photodynamic Therapy
Amos-Tautua, B., Songca, S., & Oluwafemi, O. (2019) · Molecules · doi:10.3390/molecules24132456 · Cited by 289
Features of third generation photosensitizers used in anticancer photodynamic therapy: Review
Mfouo-Tynga, I. S., Dias, L. D., Inada, N. M., & Kurachi, C. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.102091 · Cited by 260
Photodynamic therapy of lung cancer, where are we?
Crous, A., & Abrahamse, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.932098 · Cited by 38
Metadata
- Authors
- Josefsen, L. B., & Boyle, R. W.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-05
- Volume
- 154
- Issue
- 1
- Pages
- 1-3
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2158428798
- Cited by
- 229
- References
- 0
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.